Continuous glucose monitoring (CGM) has transformed diabetes management by providing real-time glucose data that finger-prick testing cannot match. Beyond its immediate utility for dosing decisions, emerging research suggests that CGM-derived metrics — particularly glucose variability — may be powerful predictors of cardiovascular risk, offering insights that HbA1c alone cannot provide. Beyond HbA1c: Why Glucose Variability…
English 
Urdu